During the past decade, Center for Digestive Diseases Eppendorf conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Center for Digestive Diseases Eppendorf" are "Eosinophilic Esophagitis" (3 trials). Many other conditions were trialed in "Center for Digestive Diseases Eppendorf" in a lesser frequency.

Most popular intervention types in "Center for Digestive Diseases Eppendorf" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Budesonide 1mg orodispersible tablet twice daily" (2 trials), "Placebo orodispersible tablet twice daily" (2 trials), "Budesonide 0.5mg orodispersible tablet twice daily" (1 trials), "Placebo" (1 trials) and "high dose budesonide suspension" (1 trials). Other intervention names were less common.

The vast majority of trials in "Center for Digestive Diseases Eppendorf" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Center for Digestive Diseases Eppendorf". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Center for Digestive Diseases Eppendorf, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Center for Digestive Diseases Eppendorf, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".